Results 171 to 180 of about 53,816 (275)

A multi-institutional experience of MR-guided liver stereotactic body radiation therapy [PDF]

, 2019
et al,, Green, Olga L, Henke, Lauren E, Parikh, Parag J   +3 more
core   +1 more source

Clinical implementation of stereotactic body radiation therapy in pancreatic cancer and hepatocellular carcinoma

, 2015
Huojun Zhang, Xiaofei Zhu
openalex   +1 more source

The Mechanism Underlying the Abnormal Expression of α‐Synuclein in the Cortical Lesions of Patients With FCD Type IIb and TSC

CNS Neuroscience &Therapeutics, Volume 32, Issue 4, April 2026.
The mTOR/GLT‐1 pathway abnormality induces α‐synucleinopathy, contributing to seizures in FCD lesions, which were rescued by treatment with the mTOR inhibitor Rapa or the GLT‐1 enhancer Cef. Intracerebroventricular α‐syn administration attenuated PTZ‐induced seizures in FCD models.
Li Zhang, Jian‐Ping Song, Jun Huang, Ping Liang, Hui Yang, Chun‐Qing Zhang, Kai‐Feng Shen   +6 more
wiley   +1 more source

Prospective Evaluation of Stereotactic Body Radiation Therapy for Reirradiation of Bone Metastases. [PDF]

Adv Radiat Oncol
Hammoudeh L, Shin KY, Hertan L, Krishnan M, Spektor A, Huynh MA, Fisher C, Balboni T.   +7 more
europepmc   +1 more source

Synchrotron‐generated microbeams as a radiosurgical alternative for drug‐resistant epilepsies: Proof of concept in a mouse model of mesiotemporal lobe epilepsy

Epilepsia, Volume 67, Issue 4, Page 1614-1626, April 2026.
Abstract Objective One‐third of patients with epilepsy, particularly those with mesial temporal lobe epilepsy (MTLE), remain resistant to medication. Resective surgery, the gold standard, is highly invasive and carries significant risks. Here, using a mouse model, we explored the potential of microbeam radiation therapy (MRT), a new technique based on ...
Loan Samalens, Camille Beets, Clothilde Courivaud, Sarvenaz Keshmiri, Jean‐François Adam, Paolo Pellicioli, Emmanuel Luc Barbier, Raphaël Serduc, Antoine Depaulis   +8 more
wiley   +1 more source

A Pilot Trial of Two-Fraction Stereotactic Body Radiation Therapy for Localized Prostate Cancer. [PDF]

Cureus
Shen X, Chen M, Cao Y, Schroeder A, Miller L, Shiao JC.   +5 more
europepmc   +1 more source

Clinical Advantages of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography/Magnetic Resonance in Radiotherapy: A Narrative Review

iRADIOLOGY, Volume 4, Issue 2, Page 71-85, April 2026.
Review the clinical application of PET multimodal imaging and compare its clinical advantages. ABSTRACT Positron emission tomography (PET)–based multimodal imaging, including PET/computed tomography (PET/CT) and PET/magnetic resonance (PET/MR), plays an increasingly important role in precision radiotherapy by integrating metabolic and anatomical ...
Yingze Fu, Jyh‐Cheng Chen, Zhongying Ma, Junchi Ma, Jianfeng Qiu   +4 more
wiley   +1 more source

Outcome and Toxicity Profile of Stereotactic Body Radiation Therapy for Adrenal Tumours in Dogs. [PDF]

Vet Comp Oncol
Thorsen L, Law K, Walz J, Coll VM, Naramor A, Maitz C, Kubicek L, Thorsen Z, Gutti JR, Takada M.   +9 more
europepmc   +1 more source

Modeling of Tumor Control Probability in Stereotactic Body Radiation Therapy for Adrenal Tumors

, 2021
Priscilla K. Stumpf, Ellen Yorke, Issam El Naqa, Kyle C. Cuneo, Jimm Grimm, Karyn A. Goodman   +5 more
openalex   +2 more sources

Isocitrate Dehydrogenase‐Mutant Astrocytomas: Risk Stratification and Therapeutic Advance

MedComm, Volume 7, Issue 4, April 2026.
This graphical abstract synthesizes the core logic of our revised review by linking integrated diagnosis, risk stratification, and trajectory‐based management in IDH‐mutant astrocytomas across CNS WHO Grades 2–4. It highlights lineage‐defining molecular classification (IDH mutation with core co‐alterations), integrated histomolecular grading, and key ...
Shepeng Wei, Xuxu Xu, Jing Bao, Zhenjiang Pan   +3 more
wiley   +1 more source